# Entellus Medical acquires Spirox for $81M

Entellus Medical has agreed to acquire Spirox, a maker of the Latera Absorbable Nasal Implant, for $25 million in cash and approximately 3.4 million shares of Entellus common stock worth about $56 million.

- Type: Acquisition
- Announced: 2017-07-07
- Where: United States
- Value: $81.0M
- Status: announced
- Products: Latera Absorbable Nasal Implant
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Entellus Medical](https://endata.com/companies/25423.md) (acquirer)
- [Spirox](https://endata.com/companies/25424.md) (target)

## Sources

- [tcbmag.com](https://tcbmag.com/entellus-unveils-81m-merger-plan-with-spirox/), 2017-07-07: "We believe this combination [of Entellus and Spirox] will enhance the near and long-term growth potential of our business and bolster our strategy to deliver less invasive treatment options to ENTs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
